HEAR FROM PEERS
Peer-to-peer learning hub
Improving ILD Diagnosis and Predicting Clinical Progression with the Envisia Genomic Classifier
Speakers discuss updated IPF/PPF guidelines, key utility data, and the role of the Envisia Genomic Classifier in the diagnosis and prognosis of ILD. New data is presented that demonstrates how the Envisia Classifier can predict clinical progression in fibrotic ILD.
Case Studies & Presentations
Envisia resource library
Watch case studies and testimonials from physicians or on-demand videos about Envisia and its clinical utility.
Utility of Envisia Genomic Classifier in Multi Disciplinary ILD Management at ATS 2021
Envisia Physician Testimonial
Detects genomic UIP pattern to improve ILD diagnostic confidence
Usual interstitial pneumonia (UIP) is a critical factor in differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILDs). The Envisia classifier improves ILD diagnostic and prognostic confidence, and can identify twice as many UIP patients than radiology alone when combined with HRCT.